Comprehensive metabolomics study identifies SN-38 organ specific toxicity in mice
Abstract SN-38 (7-ethyl-10-hydroxycamptothecin), the active metabolite of irinotecan, is a crucial anticancer agent frequently studied in drug delivery systems. Irinotecan (CPT-11) is used to treat various solid tumors but is associated with adverse effects such as nausea, vomiting, diarrhea, and st...
Saved in:
| Main Authors: | Xiaodong Zhu, Ya Huang, Jianguo Liu, Bo Kong, Changmeng Cui, Guangkui Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01753-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lignin-Based Nanocarrier for Simultaneous Delivery of <sup>131</sup>I and SN-38 in the Combined Treatment of Solid Tumors by a Nanobrachytherapy Approach
by: Aleksandar Vukadinović, et al.
Published: (2025-01-01) -
Synthesis and Characterization of Transferrin Receptor-Targeted Peptide Combination SN-38 and Rucaparib Conjugate for the Treatment of Glioblastoma
by: Perpetue Bataille Backer, et al.
Published: (2025-06-01) -
Metabolomic studies in pulmonology
by: R. R. Furina
Published: (2015-02-01) -
Albumin-based nanoparticles encapsulating SN-38 demonstrate superior antitumor efficacy compared to irinotecan
by: Guojun Xiong, et al.
Published: (2025-12-01) -
Metabolomics Analysis of Chemical Constituents in Compressed Shoumei White Tea with Different Storage Periods
by: SUN Ruofan, GAO Jianjian, ZHOU Danyang, TAN Junfeng, LIN Zhi, DAI Weidong
Published: (2025-04-01)